Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?

References

• Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–47.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381–90.
   PubMedGoogle Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kin. 1970;3: 393–403.
   PubMedGoogle Scholar
• Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17: 331–40.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ. Marrow stromal fibroblasts. Calcif Tissue Int. 1995;56(Suppl 1):S17.
   Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136: 42–60.
   PubMedGoogle Scholar
• Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9: 641–50.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest. 1998;101:1737–44.
   PubMed Web of Science ®Google Scholar
• Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78:55–62.
   PubMed Web of Science ®Google Scholar
• Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest. 2000;105:1663–8.
   PubMed Web of Science ®Google Scholar
• Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313–9.
   PubMed Web of Science ®Google Scholar
• Bianco P, Robey PG, Saggio I, Riminucci M. ‘Mesenchymal’ stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Human Gene Ther. 2010;21:1057–66.
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396–402.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells. Ann NY Acad Sci. 2009;1176:101–17.
   PubMed Web of Science ®Google Scholar
• Sabatini F, Petecchia L, Tavian M, Jodon de Villeroche V, Rossi GA, Brouty-Boye D. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest J Tech Meth Pathol. 2005;85:962–71.
   PubMed Web of Science ®Google Scholar
• Lorenz K, Sicker M, Schmelzer E, Rupf T, Salvetter J, Schulz-Siegmund M, . Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol. 2008;17:925–32.
   PubMed Web of Science ®Google Scholar
• Covas DT, Panepucci RA, Fontes AM, Silva WA Jr, Orellana MD, Freitas MC, . Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol. 2008;36:642–54.
   PubMed Web of Science ®Google Scholar
• Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM. Human skin fibroblasts: from mesodermal to hepatocyte-like differentiation. Hepatology. 2007;46:1574–85.
   PubMedGoogle Scholar
• Blasi A, Martino C, Balducci L, Saldarelli M, Soleti A, Navone SE, . Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell. 2011;3:5.
   PubMedGoogle Scholar
• Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, . Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289–301.
   PubMed Web of Science ®Google Scholar
• Hanson SE, Kim J, Johnson BH, Bradley B, Breunig MJ, Hematti P, . Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope. 2010;120:546–51.
   Google Scholar
• Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA, Titeux M, Winterton P, Casteilla L, . Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol. 2010;30:607–19.
   PubMed Web of Science ®Google Scholar
• Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, . Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402–16.
   PubMed Web of Science ®Google Scholar
• Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol. 2008;36:350–9.
   PubMedGoogle Scholar
• Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007;109:1743–51.
   PubMed Web of Science ®Google Scholar
• Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239–48.
   PubMed Web of Science ®Google Scholar
• Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10:320–30.
   PubMed Web of Science ®Google Scholar
• Samuelsson H, Ringden O, Lonnies H, Le Blanc K. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy. 2009;11: 129–36.
   PubMed Web of Science ®Google Scholar
• Schellenberg A, Stiehl T, Horn P, Joussen S, Pallua N, Ho AD, Wagner W. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy. 2012;14: 401–11.
   PubMed Web of Science ®Google Scholar
• Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, . Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA. 2002;99:12877–82.
   PubMed Web of Science ®Google Scholar
• Graf T. Historical origins of transdifferentiation and reprogramming. Cell Stem Cell. 2011;9:504–16.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
   PubMed Web of Science ®Google Scholar
• Lushaj EB, Anstadt E, Haworth R, Roenneburg D, Kim J, Hematti P, . Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy. 2011;13:400–6.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Lalykina KS. Thymus cells are inducible to osteogenesis. Eur J Immunol. 1972;2:602–3.
   PubMedGoogle Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–506.
   PubMed Web of Science ®Google Scholar
• Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009;37:1445–53.
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 2009;17:939–46.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Current views. Stem Cells. 2007;25:2896–902.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy. 2008; 10:771–4.
   PubMed Web of Science ®Google Scholar
• Haniffa MA, Collin MP, Buckley CD, Dazzi F. Mesenchymal stem cells: the fibroblasts’ new clothes? Haematologica. 2009;94:258–63.
   PubMed Web of Science ®Google Scholar
• Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol. 2007;179:2824–31.
   Google Scholar
• Donnelly JJ, Xi MS, Rockey JH. A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma. Exp Eye Res. 1993;56:157–65.
   PubMed Web of Science ®Google Scholar
• Le JM, Vilcek J. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. J Immunol. 1987;139:3330–7.
   PubMedGoogle Scholar
• Shimabukuro Y, Murakami S, Okada H. Interferon-gamma-dependent immunosuppressive effects of human gingival fibroblasts. Immunology. 1992;76:344–7.
   PubMed Web of Science ®Google Scholar
• Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, . Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386–98.
   PubMed Web of Science ®Google Scholar
• Theobald VA, Lauer JD, Kaplan FA, Baker KB, Rosenberg M. ‘Neutral allografts’: lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation. 1993;55:128–33.
   PubMedGoogle Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890–6.
   PubMed Web of Science ®Google Scholar
• Korn JH. Modulation of lymphocyte mitogen responses by cocultured fibroblasts. Cell Immunol. 1981;63:374–84.
   PubMedGoogle Scholar
• Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther J Am Soc Gene Ther. 2012;20:14–20.
   PubMed Web of Science ®Google Scholar
• Brockes JP, Kumar A, Velloso CP. Regeneration as an evolutionary variable. J Anatomy. 2001;199:3–11.
   PubMed Web of Science ®Google Scholar
• Bayat A, McGrouther DA, Ferguson MW. Skin scarring. Br Med J. 2003;326:88–92.
   PubMed Web of Science ®Google Scholar
• Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 2007;257:143–79.
   PubMed Web of Science ®Google Scholar
• Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514–25.
   PubMed Web of Science ®Google Scholar
• Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975;78:71–100.
   PubMed Web of Science ®Google Scholar
• Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, . Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010;45:1732–40.
   PubMed Web of Science ®Google Scholar
• Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review. Hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010;28:1446–55.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995;16:557–64.
   PubMed Web of Science ®Google Scholar
• Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307–16.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, . Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309–13.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11:503–15.
   PubMed Web of Science ®Google Scholar
• Chhetri DK, Berke GS. Injection of cultured autologous fibroblasts for human vocal fold scars. Laryngoscope. 2011;121:785–92.
   PubMedGoogle Scholar
• Obaid H, Clarke A, Rosenfeld P, Leach C, Connell D. Skin-derived fibroblasts for the treatment of refractory achilles tendinosis: preliminary short-term results. J Bone Joint Surg Am. 2012;94:193–200.
   PubMedGoogle Scholar